Synthetic lethality: a step forward for personalized medicine in cancer
- 1 February 2020
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 25 (2) , 305-320
Abstract
No abstract availableKeywords
Funding Information
- University of Michigan
This publication has 156 references indexed in Scilit:
- A Role for Cytosolic Fumarate Hydratase in Urea Cycle Metabolism and Renal NeoplasiaCell Reports, 2013
- ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine DeprivationCancer Cell, 2012
- Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cellsEMBO Molecular Medicine, 2012
- Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategiesCell Research, 2012
- Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminaseBritish Journal of Cancer, 2012
- A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung CarcinomaCancer Cell, 2010
- Synthetic lethal targeting of PTEN mutant cells with PARP inhibitorsEMBO Molecular Medicine, 2009
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras OncogeneCell, 2009
- p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA DamageCancer Cell, 2007
- Role of poly(ADP-ribose) formation in DNA repairNature, 1992